Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).
Quick Stats
Jan 30, 202656.9
AI Score
HOLD0.0
Volume Ratio
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
CANF Stock Summary
Last updated Jan 30, 2026
CANF is currently trading at $4.01, positioned above its 200-day moving average of $1.06, indicating a long-term uptrend. The stock has a 52-week range of $0.1678 to $4.85.
Technical Analysis: The 50-day moving average stands at $1.79, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 63.864, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.626, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates CANF at 56.9/100 with a HOLD recommendation.
CANF (Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 63.864 |
| CMF (20) | 0.626 |
| ROC (10) | -6.308 |
| ADX (14) | 55.288 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.744 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -81.29 |
| MFI (14) | 56.014 |
CANF Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CANF Price vs Max Options Open Interest
CANF Max Change In Options Open Interest
CANF Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CANF Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CANF Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CANF Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares is above both 50 Day and 200 Day SMA which is considered Bullish.
CANF Moving Averages Analysis
Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
CANF (Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 4.22 |
| 20 | 4.04 |
| 30 | 2.77 |
| 50 | 1.79 |
| 100 | 1.16 |
| 200 | 1.06 |
CANF Fundamental Analysis
| P/E (Forward) | 2.9665 |
| P/E (Trailing) | 0 |
| Market Cap ($) | 15.2 million |
| Earnings/Share ($) | 0 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.52 |
| EPS Estimate Next Year ($) | -0.04 |
| WallStreet Target Price ($) | 3.5 |
| Most Recent Quarter |